Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Clinical trial NCT02739165 · COMPLETED
Trial details
- NCT number
- NCT02739165
- Sponsor
- Asahi Kasei Therapeutics Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2018-09-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.